Related Experiment Video
Updated: Jun 14, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Drug-Target Interactions Prediction at Scale: The Komet Algorithm with the LCIdb Dataset
Gwenn Guichaoua1,2,3, Philippe Pinel1,2,3,4, Brice Hoffmann4
1Center for Computational Biology (CBIO), Mines Paris-PSL, 75006 Paris, France.
This study introduces LCIdb, a large drug-target interaction dataset, and Komet, a scalable prediction pipeline. Komet outperforms deep learning methods for drug discovery and target identification.
Area of Science:
- Computational chemistry and cheminformatics
- Bioinformatics and computational biology
- Drug discovery and development
Background:
- Drug-target interactions (DTIs) prediction is crucial for drug discovery, aiding in target deorphanization and identification.
- Existing DTI prediction methods often struggle with scalability and broad applicability across diverse molecular and protein spaces.
- Developing large, high-quality datasets and efficient, scalable prediction algorithms are key challenges.
Purpose of the Study:
- To address the challenges of building large DTI datasets and developing scalable prediction methods.
- To introduce LCIdb, a comprehensive dataset for DTI prediction, expanding molecule space coverage.
- To propose Komet, a novel, scalable DTI prediction pipeline designed for high performance on large datasets.
Main Methods:
- Creation of LCIdb, a large, curated dataset of DTIs with extensive molecule and protein coverage.
- Development of Komet, a DTI prediction pipeline utilizing a Kronecker interaction module and Nyström approximation.
- Implementation of Komet with efficient computation, GPU parallelization, and quasi-Newton optimization for scalability.
Main Results:
- Komet demonstrates superior scalability and prediction performance compared to state-of-the-art deep learning approaches.
- The pipeline shows strong generalization capabilities on external datasets and scaffold hopping benchmarks.
- LCIdb provides significantly broader molecule space coverage than existing public benchmarks.
Conclusions:
- Komet offers an efficient and high-performing solution for large-scale DTI prediction in drug discovery.
- The developed methods and datasets facilitate advancements in identifying novel drug-target relationships.
- Open-source availability of Komet and datasets promotes further research and application in the field.
More Related Videos
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
Protein-protein Interfaces
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...